(Q36169756)

12 August 2017

1 reference

title

Molecular and cellular targets of anti-IgE antibodies (English)

1 reference

12 August 2017

2

Crameri R

1 reference

12 August 2017

Inführ D

1

1 reference

12 August 2017

Lamers R

series ordinal

3

1 reference

12 August 2017

Achatz G

series ordinal

4

1 reference

12 August 2017

publication date

1 August 2005

1 reference

12 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Allergy

1 reference

12 August 2017

volume

60

1 reference

12 August 2017

issue

8

1 reference

12 August 2017

page(s)

977-985

1 reference

The B-cell antigen receptor of the five immunoglobulin classes

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Effect of transmembrane and cytoplasmic domains of IgE on the IgE response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

An epitope on membrane-bound but not secreted IgE: implications in isotype-specific regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Can anti-IgE be used to treat allergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

The pharmacological basis of anti-IgE therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Therapeutic potential of anti-IgE antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Monoclonal antibodies defining epitopes on human IgE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

A polyclonal model for B-cell tolerance. II. Linkage between signaling of B-cell egress from G0, class II upregulation and unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Models of signal transduction through the B-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Reduced life span of anergic self-reactive B cells in a double-transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Pathways of apoptosis in lymphocyte development, homeostasis, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Monoclonal antibodies against the C(epsilon)mX domain of human membrane-bound IgE and their potential use for targeting IgE-expressing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Effect of anti-IgE therapy in patients with peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Anti-IgE: a significant breakthrough in the treatment of airway allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Coding single nucleotide polymorphism in the high-affinity immunoglobulin E receptor b chain (FcepsilonRI-beta) gene is associated with immunoglobulin E receptor-mediated histamine release from basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Cytokine-directed therapies for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00832.X

10.1111/J.1398-9995.2005.00832.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference